Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1915 entries
Sorted by: Best Match Show Resources per page
Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?.

Journal of clinical medicine

De Vecchis R, Cantatrione C, Mazzei D, Baldi C.
PMID: 27706088
J Clin Med. 2016 Oct 02;5(10). doi: 10.3390/jcm5100086.

In the congestive heart failure (CHF) setting, chronic hyponatremia is very common. The present review aims at addressing topics relevant to the pathophysiology of hyponatremia in the course of CHF as well as its optimal treatment, including the main...

Cite
De Vecchis R, Cantatrione C, Mazzei D, et al. Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?. J Clin Med. 2016;5(10)doi: 10.3390/jcm5100086.
De Vecchis, R., Cantatrione, C., Mazzei, D., & Baldi, C. (2016). Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?. Journal of clinical medicine, 5(10), . https://doi.org/10.3390/jcm5100086
De Vecchis, Renato, et al. "Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?." Journal of clinical medicine vol. 5,10 (2016). doi: https://doi.org/10.3390/jcm5100086
De Vecchis R, Cantatrione C, Mazzei D, Baldi C. Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?. J Clin Med. 2016 Oct 02;5(10). doi: 10.3390/jcm5100086. PMID: 27706088; PMCID: PMC5086588.
Copy Download .nbib Format: NLM
[Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Shandalin VA, Fonyakin AV, Geraskina LA, Samokhvalova EV.
PMID: 26978638
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(12):37-42. doi: 10.17116/jnevro201511512237-42.

OBJECTIVE: To establish prognostic factors of recurrent acute cerebrovascular complications after ischemic stroke.MATERIAL AND METHODS: A prospective observational study on the 21-22nd day of the acute stage of ischemic stroke included 148 patients, aged 60 [5; 68] years. Following...

Cite
Shandalin VA, Fonyakin AV, Geraskina LA, et al. Prognosticheskie faktory razvitiya povtornykh ostrykh narushenii mozgovogo krovoobrashcheniya u bol'nykh s ishemicheskim insul'tom. [Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(12):37-42doi: 10.17116/jnevro201511512237-42.
Shandalin, V. A., Fonyakin, A. V., Geraskina, L. A., & Samokhvalova, E. V. (2015). Prognosticheskie faktory razvitiya povtornykh ostrykh narushenii mozgovogo krovoobrashcheniya u bol'nykh s ishemicheskim insul'tom. [Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 115(12), 37-42. https://doi.org/10.17116/jnevro201511512237-42
Shandalin, V A, et al. "Prognosticheskie faktory razvitiya povtornykh ostrykh narushenii mozgovogo krovoobrashcheniya u bol'nykh s ishemicheskim insul'tom." [Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 115,12 (2015): 37-42. doi: https://doi.org/10.17116/jnevro201511512237-42
Shandalin VA, Fonyakin AV, Geraskina LA, Samokhvalova EV. Prognosticheskie faktory razvitiya povtornykh ostrykh narushenii mozgovogo krovoobrashcheniya u bol'nykh s ishemicheskim insul'tom. [Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(12):37-42. doi: 10.17116/jnevro201511512237-42. Russian. PMID: 26978638.
Copy Download .nbib Format: NLM
Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature.

Frontiers in cardiovascular medicine

Narang N, Lang RM, Liarski VM, Jeevanandam V, Hofmann Bowman MA.
PMID: 28396860
Front Cardiovasc Med. 2017 Mar 27;4:14. doi: 10.3389/fcvm.2017.00014. eCollection 2017.

A 55-year-old man with a history of erosive, seropositive rheumatoid arthritis (RA), and interstitial lung disease presented with shortness of breath. Echocardiography showed new-onset severe left ventricular (LV) dysfunction with an ejection fraction (EF) of 15% and moderately increased...

Cite
Narang N, Lang RM, Liarski VM, et al. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Front Cardiovasc Med. 2017;4:14doi: 10.3389/fcvm.2017.00014.
Narang, N., Lang, R. M., Liarski, V. M., Jeevanandam, V., & Hofmann Bowman, M. A. (2017). Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Frontiers in cardiovascular medicine, 414. https://doi.org/10.3389/fcvm.2017.00014
Narang, Nikhil, et al. "Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature." Frontiers in cardiovascular medicine vol. 4 (2017): 14. doi: https://doi.org/10.3389/fcvm.2017.00014
Narang N, Lang RM, Liarski VM, Jeevanandam V, Hofmann Bowman MA. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-A Case Report and Review of the Literature. Front Cardiovasc Med. 2017 Mar 27;4:14. doi: 10.3389/fcvm.2017.00014. eCollection 2017. PMID: 28396860; PMCID: PMC5366320.
Copy Download .nbib Format: NLM
Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites.

Hepatology research : the official journal of the Japan Society of Hepatology

Kogiso T, Yamamoto K, Kobayashi M, Ikarashi Y, Kodama K, Taniai M, Torii N, Hashimoto E, Tokushige K.
PMID: 27670393
Hepatol Res. 2017 Aug;47(9):835-844. doi: 10.1111/hepr.12822. Epub 2016 Nov 15.

AIM: The vasopressin V2 receptor antagonist tolvaptan has been used for the treatment of cirrhotic patients with ascites; however, no predictor of efficacy and prognosis has been developed. We evaluated candidate predictors of response to tolvaptan treatment.METHODS: This was...

Cite
Kogiso T, Yamamoto K, Kobayashi M, et al. Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites. Hepatol Res. 2016;47(9):835-844doi: 10.1111/hepr.12822.
Kogiso, T., Yamamoto, K., Kobayashi, M., Ikarashi, Y., Kodama, K., Taniai, M., Torii, N., Hashimoto, E., & Tokushige, K. (2017). Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites. Hepatology research : the official journal of the Japan Society of Hepatology, 47(9), 835-844. https://doi.org/10.1111/hepr.12822
Kogiso, Tomomi, et al. "Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,9 (2017): 835-844. doi: https://doi.org/10.1111/hepr.12822
Kogiso T, Yamamoto K, Kobayashi M, Ikarashi Y, Kodama K, Taniai M, Torii N, Hashimoto E, Tokushige K. Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites. Hepatol Res. 2017 Aug;47(9):835-844. doi: 10.1111/hepr.12822. Epub 2016 Nov 15. PMID: 27670393.
Copy Download .nbib Format: NLM
Erratum to: Diuretics-assisted treatment of chronic laxative abuse.

CEN case reports

Shirasawa Y, Fukuda M, Kimura G.
PMID: 28509204
CEN Case Rep. 2014 Nov;3(2):215-216. doi: 10.1007/s13730-014-0123-4.

No abstract available.

Cite
Shirasawa Y, Fukuda M, Kimura G. Erratum to: Diuretics-assisted treatment of chronic laxative abuse. CEN Case Rep. 2014;3(2):215-216doi: 10.1007/s13730-014-0123-4.
Shirasawa, Y., Fukuda, M., & Kimura, G. (2014). Erratum to: Diuretics-assisted treatment of chronic laxative abuse. CEN case reports, 3(2), 215-216. https://doi.org/10.1007/s13730-014-0123-4
Shirasawa, Yuichi, et al. "Erratum to: Diuretics-assisted treatment of chronic laxative abuse." CEN case reports vol. 3,2 (2014): 215-216. doi: https://doi.org/10.1007/s13730-014-0123-4
Shirasawa Y, Fukuda M, Kimura G. Erratum to: Diuretics-assisted treatment of chronic laxative abuse. CEN Case Rep. 2014 Nov;3(2):215-216. doi: 10.1007/s13730-014-0123-4. PMID: 28509204; PMCID: PMC5413666.
Copy Download .nbib Format: NLM
[Prognostic Factors of Cardiovascular Complications After Ischemic Stroke].

Kardiologiia

Shandalin VA, Fonyakin AV, Geraskina LA, Suslina ZA.
PMID: 28294721
Kardiologiia. 2015 Nov;55(11):61-68.

We included into prospective cohort observational study 148 patients with ischemic stroke aged 60 [52; 68] years. Duration of a prospective follow-up was 35 [28; 40] months. Cardiovascular events (CVE) registered during follow-up were recurrent stroke, transient ischemic attack,...

Cite
Shandalin VA, Fonyakin AV, Geraskina LA, et al. [Prognostic Factors of Cardiovascular Complications After Ischemic Stroke]. Kardiologiia. 2015;55(11):61-68
Shandalin, V. A., Fonyakin, A. V., Geraskina, L. A., & Suslina, Z. A. (2015). [Prognostic Factors of Cardiovascular Complications After Ischemic Stroke]. Kardiologiia, 55(11), 61-68.
Shandalin, V A, et al. "[Prognostic Factors of Cardiovascular Complications After Ischemic Stroke]." Kardiologiia vol. 55,11 (2015): 61-68.
Shandalin VA, Fonyakin AV, Geraskina LA, Suslina ZA. [Prognostic Factors of Cardiovascular Complications After Ischemic Stroke]. Kardiologiia. 2015 Nov;55(11):61-68. Russian. PMID: 28294721.
Copy Download .nbib Format: NLM
Scrotal Swelling as a Complication of Hydrochlorothiazide Induced Acute Pancreatitis.

Case reports in gastrointestinal medicine

Nikiforov I, Mansoora Q, Al-Khalisy H, Joseph S, Cheriyath P.
PMID: 26199765
Case Rep Gastrointest Med. 2015;2015:265273. doi: 10.1155/2015/265273. Epub 2015 Jun 24.

Background. Scrotal swelling is a rare complication of acute pancreatitis with few reported cases in the literature. In this case report, we present a 59-year-old male with hydrochlorothiazide induced pancreatitis who developed scrotal swelling. Case Presentation. A 59-year-old male...

Cite
Nikiforov I, Mansoora Q, Al-Khalisy H, et al. Scrotal Swelling as a Complication of Hydrochlorothiazide Induced Acute Pancreatitis. Case Rep Gastrointest Med. 2015;2015:265273doi: 10.1155/2015/265273.
Nikiforov, I., Mansoora, Q., Al-Khalisy, H., Joseph, S., & Cheriyath, P. (2015). Scrotal Swelling as a Complication of Hydrochlorothiazide Induced Acute Pancreatitis. Case reports in gastrointestinal medicine, 2015265273. https://doi.org/10.1155/2015/265273
Nikiforov, Ivan, et al. "Scrotal Swelling as a Complication of Hydrochlorothiazide Induced Acute Pancreatitis." Case reports in gastrointestinal medicine vol. 2015 (2015): 265273. doi: https://doi.org/10.1155/2015/265273
Nikiforov I, Mansoora Q, Al-Khalisy H, Joseph S, Cheriyath P. Scrotal Swelling as a Complication of Hydrochlorothiazide Induced Acute Pancreatitis. Case Rep Gastrointest Med. 2015;2015:265273. doi: 10.1155/2015/265273. Epub 2015 Jun 24. PMID: 26199765; PMCID: PMC4495177.
Copy Download .nbib Format: NLM
Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.

World journal of methodology

Al Shibli A, Narchi H.
PMID: 26140272
World J Methodol. 2015 Jun 26;5(2):55-61. doi: 10.5662/wjm.v5.i2.55. eCollection 2015 Jun 26.

Bartter and Gitelman syndromes (BS and GS) are inherited disorders resulting in defects in renal tubular handling of sodium, potassium and chloride. Previously considered as genotypic and phenotypic heterogeneous diseases, recent evidence suggests that they constitute a spectrum of...

Cite
Al Shibli A, Narchi H. Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. World J Methodol. 2015;5(2):55-61doi: 10.5662/wjm.v5.i2.55.
Al Shibli, A., & Narchi, H. (2015). Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. World journal of methodology, 5(2), 55-61. https://doi.org/10.5662/wjm.v5.i2.55
Al Shibli, Amar, and Narchi, Hassib. "Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations." World journal of methodology vol. 5,2 (2015): 55-61. doi: https://doi.org/10.5662/wjm.v5.i2.55
Al Shibli A, Narchi H. Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. World J Methodol. 2015 Jun 26;5(2):55-61. doi: 10.5662/wjm.v5.i2.55. eCollection 2015 Jun 26. PMID: 26140272; PMCID: PMC4482822.
Copy Download .nbib Format: NLM
Hypertensive patients with and without kidney disease: assessment of risk factors.

Revista da Escola de Enfermagem da U S P

Pinho NA, Oliveira Rde C, Pierin AM.
PMID: 26761699
Rev Esc Enferm USP. 2015 Feb;49:101-8. doi: 10.1590/S0080-623420150000700015.

Objective To compare hypertensive patients with and without chronic kidney disease and identify factors associated with their clinical condition and antihypertensive treatment. Method This was a cross-sectional study conducted with patients hospitalized in a general medical ward at a...

Cite
Pinho NA, Oliveira Rde C, Pierin AM. Hipertensos com e sem doença renal: avaliação de fatores de risco. Hypertensive patients with and without kidney disease: assessment of risk factors. Rev Esc Enferm USP. 2015;49:101-8doi: 10.1590/S0080-623420150000700015.
Pinho, N. A., Oliveira, R. d. e. . C., & Pierin, A. M. (2015). Hipertensos com e sem doença renal: avaliação de fatores de risco. Hypertensive patients with and without kidney disease: assessment of risk factors. Revista da Escola de Enfermagem da U S P, 49101-8. https://doi.org/10.1590/S0080-623420150000700015
Pinho, Natália Alencar de, et al. "Hipertensos com e sem doença renal: avaliação de fatores de risco." Hypertensive patients with and without kidney disease: assessment of risk factors. Revista da Escola de Enfermagem da U S P vol. 49 (2015): 101-8. doi: https://doi.org/10.1590/S0080-623420150000700015
Pinho NA, Oliveira Rde C, Pierin AM. Hipertensos com e sem doença renal: avaliação de fatores de risco. Hypertensive patients with and without kidney disease: assessment of risk factors. Rev Esc Enferm USP. 2015 Feb;49:101-8. doi: 10.1590/S0080-623420150000700015. Portuguese. PMID: 26761699.
Copy Download .nbib Format: NLM
UTILISATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS IN BOSNIA AND HERZEGOVINA FOR THE TIME-PERIOD 2013-2015.

Materia socio-medica

Selmanovic K, Zec SL, Vanis N, Zecevic L, Setkic M, Rasic A, Zerem E.
PMID: 27147917
Mater Sociomed. 2016 Apr;28(2):116-20. doi: 10.5455/msm.2016.28.116-120. Epub 2016 Mar 25.

OBJECTIVE: Expenditures for drugs are increasingly burdening already insufficient funds for health protection. This is especially evident in less developed European countries such as Bosnia and Herzegovina. The question is whether such analyses can help save funds for financing...

Cite
Selmanovic K, Zec SL, Vanis N, et al. UTILISATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS IN BOSNIA AND HERZEGOVINA FOR THE TIME-PERIOD 2013-2015. Mater Sociomed. 2016;28(2):116-20doi: 10.5455/msm.2016.28.116-120.
Selmanovic, K., Zec, S. L., Vanis, N., Zecevic, L., Setkic, M., Rasic, A., & Zerem, E. (2016). UTILISATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS IN BOSNIA AND HERZEGOVINA FOR THE TIME-PERIOD 2013-2015. Materia socio-medica, 28(2), 116-20. https://doi.org/10.5455/msm.2016.28.116-120
Selmanovic, Kenan, et al. "UTILISATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS IN BOSNIA AND HERZEGOVINA FOR THE TIME-PERIOD 2013-2015." Materia socio-medica vol. 28,2 (2016): 116-20. doi: https://doi.org/10.5455/msm.2016.28.116-120
Selmanovic K, Zec SL, Vanis N, Zecevic L, Setkic M, Rasic A, Zerem E. UTILISATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS IN BOSNIA AND HERZEGOVINA FOR THE TIME-PERIOD 2013-2015. Mater Sociomed. 2016 Apr;28(2):116-20. doi: 10.5455/msm.2016.28.116-120. Epub 2016 Mar 25. PMID: 27147917; PMCID: PMC4851497.
Copy Download .nbib Format: NLM
Management of the cardiorenal syndrome in decompensated heart failure.

Cardiorenal medicine

Verbrugge FH, Grieten L, Mullens W.
PMID: 25737682
Cardiorenal Med. 2014 Dec;4(3):176-88. doi: 10.1159/000366168.

BACKGROUND: The management of the cardiorenal syndrome (CRS) in decompensated heart failure (HF) is challenging, with high-quality evidence lacking.SUMMARY: The pathophysiology of CRS in decompensated HF is complex, with glomerular filtration rate (GFR) and urine output representing different aspects...

Cite
Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014;4(3):176-88doi: 10.1159/000366168.
Verbrugge, F. H., Grieten, L., & Mullens, W. (2014). Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal medicine, 4(3), 176-88. https://doi.org/10.1159/000366168
Verbrugge, Frederik Hendrik, et al. "Management of the cardiorenal syndrome in decompensated heart failure." Cardiorenal medicine vol. 4,3 (2014): 176-88. doi: https://doi.org/10.1159/000366168
Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3):176-88. doi: 10.1159/000366168. PMID: 25737682; PMCID: PMC4299260.
Copy Download .nbib Format: NLM
Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center.

Journal of clinical medicine

Barber SM, Liebelt BD, Baskin DS.
PMID: 26237599
J Clin Med. 2014 Oct 28;3(4):1199-219. doi: 10.3390/jcm3041199.

Hyponatremia is often seen after transsphenoidal surgery and is a source of considerable economic burden and patient-related morbidity and mortality. We performed a retrospective review of 344 patients who underwent transsphenoidal surgery at our institution between 2006 and 2012....

Cite
Barber SM, Liebelt BD, Baskin DS. Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center. J Clin Med. 2014;3(4):1199-219doi: 10.3390/jcm3041199.
Barber, S. M., Liebelt, B. D., & Baskin, D. S. (2014). Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center. Journal of clinical medicine, 3(4), 1199-219. https://doi.org/10.3390/jcm3041199
Barber, Sean M, et al. "Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center." Journal of clinical medicine vol. 3,4 (2014): 1199-219. doi: https://doi.org/10.3390/jcm3041199
Barber SM, Liebelt BD, Baskin DS. Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center. J Clin Med. 2014 Oct 28;3(4):1199-219. doi: 10.3390/jcm3041199. PMID: 26237599; PMCID: PMC4470178.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1915 entries